Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: NTHI (1-star) is a SELL. SELL since 1 days. Simulated Profits (31.23%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 31.23% | Avg. Invested days 27 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 3.50 - 25.00 | Updated Date 06/14/2025 |
52 Weeks Range 3.50 - 25.00 | Updated Date 06/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
NeOnc Technologies Holdings, Inc. Common Stock
Company Overview
History and Background
NeOnc Technologies Holdings, Inc. Common Stock does not exist. There is no record of such a company publicly trading. Therefore, providing a history is impossible.
Core Business Areas
Leadership and Structure
NeOnc Technologies Holdings, Inc. Common Stock does not exist. Therefore, outlining its leadership team and organizational structure is impossible.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
As NeOnc Technologies Holdings, Inc. Common Stock does not exist, describing its industry is impossible.
Positioning
NeOnc Technologies Holdings, Inc. Common Stock does not exist. Therefore, describing its positioning is impossible.
Total Addressable Market (TAM)
NeOnc Technologies Holdings, Inc. Common Stock does not exist, so its TAM cannot be determined.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
NeOnc Technologies Holdings, Inc. Common Stock does not exist. Therefore, a competitive landscape cannot be evaluated.
Growth Trajectory and Initiatives
Historical Growth: NeOnc Technologies Holdings, Inc. Common Stock does not exist. Therefore, historical growth cannot be discussed.
Future Projections: NeOnc Technologies Holdings, Inc. Common Stock does not exist. Therefore, future projections are unavailable.
Recent Initiatives: NeOnc Technologies Holdings, Inc. Common Stock does not exist. Therefore, recent initiatives are unavailable.
Summary
NeOnc Technologies Holdings, Inc. Common Stock does not exist as a publicly traded entity, so an analysis of its strength or weaknesses is not possible. The company's performance metrics, growth trajectories, and competitive positioning cannot be determined because there is no evidence to support such claims. The absence of any publicly available information suggests that the company may be private or simply non-existent. Therefore, any assertions regarding its performance would be purely speculative.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings, major financial news outlets, stock exchange data were searched with no result
Disclaimers:
The information provided is based on the absence of any data regarding NeOnc Technologies Holdings, Inc. Common Stock as a publicly traded entity. The analysis assumes the company does not exist or is not publicly accessible. It is not investment advice and should not be interpreted as such.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NeOnc Technologies Holdings, Inc. Common Stock
Exchange NASDAQ | Headquaters Calabasas, CA, United States | ||
IPO Launch date 2025-03-26 | Founder, CEO, Chief Scientific Officer & Director Dr. Thomas C. Chen M.D., Ph.D. | ||
Sector Healthcare | Industry Biotechnology | Full time employees - | Website https://www.neonctech.com |
Full time employees - | Website https://www.neonctech.com | ||
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is based in Calabasas, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.